Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms

S. Heymans; L.T. Cooper

doi:10.1038/s41569-021-00662-w

Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms

S. Heymans^*, L.T. Cooper

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

96 Citations (Web of Science)

Abstract

The risk of acute myocarditis associated with COVID-19 mRNA vaccination has garnered intense (social) media attention. However, myocarditis after COVID-19 mRNA vaccination is rare and usually resolves within days or weeks. Moreover, the risks of hospitalization and death associated with COVID-19 are greater than the risk associated with COVID-19 vaccination. Therefore, COVID-19 vaccination should be recommended in adolescents and adults.

Original language	English
Pages (from-to)	75-77
Number of pages	3
Journal	Nature Reviews Cardiology
Volume	19
Issue number	2
Early online date	9 Dec 2021
DOIs	https://doi.org/10.1038/s41569-021-00662-w
Publication status	Published - Feb 2022

Access to Document

10.1038/s41569-021-00662-w

Cite this

@article{c33c17e1979542a4bfdd40f11e8cb4f4,

title = "Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms",

abstract = "The risk of acute myocarditis associated with COVID-19 mRNA vaccination has garnered intense (social) media attention. However, myocarditis after COVID-19 mRNA vaccination is rare and usually resolves within days or weeks. Moreover, the risks of hospitalization and death associated with COVID-19 are greater than the risk associated with COVID-19 vaccination. Therefore, COVID-19 vaccination should be recommended in adolescents and adults.",

author = "S. Heymans and L.T. Cooper",

year = "2022",

month = feb,

doi = "10.1038/s41569-021-00662-w",

language = "English",

volume = "19",

pages = "75--77",

journal = "Nature Reviews Cardiology",

issn = "1759-5002",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms

AU - Heymans, S.

AU - Cooper, L.T.

PY - 2022/2

Y1 - 2022/2

N2 - The risk of acute myocarditis associated with COVID-19 mRNA vaccination has garnered intense (social) media attention. However, myocarditis after COVID-19 mRNA vaccination is rare and usually resolves within days or weeks. Moreover, the risks of hospitalization and death associated with COVID-19 are greater than the risk associated with COVID-19 vaccination. Therefore, COVID-19 vaccination should be recommended in adolescents and adults.

AB - The risk of acute myocarditis associated with COVID-19 mRNA vaccination has garnered intense (social) media attention. However, myocarditis after COVID-19 mRNA vaccination is rare and usually resolves within days or weeks. Moreover, the risks of hospitalization and death associated with COVID-19 are greater than the risk associated with COVID-19 vaccination. Therefore, COVID-19 vaccination should be recommended in adolescents and adults.

U2 - 10.1038/s41569-021-00662-w

DO - 10.1038/s41569-021-00662-w

M3 - Editorial

C2 - 34887571

SN - 1759-5002

VL - 19

SP - 75

EP - 77

JO - Nature Reviews Cardiology

JF - Nature Reviews Cardiology

IS - 2

ER -